1Johnson KM, Wieben O, Samsonov AA. Phase-contrast velocime- try with simultaneous fat/water separation [J]. Magn Reson Med, 2010, 63(6): 1564-1574.
2Stalder AF, Russe MF, Frydrychowicz A, et al. Quantitative 2D and 3D phase contrast MRI: optimized analysis of blood flow and vessel wall parameters[J]. Magn Reson Med, 2008, 60(5): 1218- 1231.
3Gatehouse PD, Keegan J, Crowe LA, et al. Applications of phase-contrast flow and velocity imaging in cardiovascular MRI [J]. Eur Radiol, 2005, 15(10): 2172-2184.
4Lotz J, Meier C, Leppert A, et al. Cardiovascular flow measure- ment with phase-contrast MR imaging: basic facts and implemen- tation[J]. Radiographics, 2002, 22(3): 651-671.
5Chai P, Mohiaddin R. How we perform cardiovascular magnetic resonance flow assessment using phase-contrast velocity mapping [J]. J Cardiovasc Magn Reson, 2005, 7(4): 705-716.
6Lotz J, Doker R, Noeske R, et al. In vitro validation of phase- contrast flow measurements at 3T in comparison to 1.5T: preci- sion, accuracy, and signal-to-noise ratios[J]. J Magn Reson Imag- ing, 2005, 21(5): 604-610.
7Komsec F, Turski P. Velocity and volume flow rate measurements using phase contrast magnetic resonance imaging[J]. Inter J Neu- roradiol, 1997, 3(4): 293-318.
8Meckel S, Leitner L, Bonati LH, et al. Intracranial artery velocity measurement using 4D PC MRI at 3T: comparison with transcra- nial ultrasound techniques and 2D PC MRI [J]. Neuroradiology, 2012.
9Epub ahead of printl. lCarlsson M, Andersson R, Bloch KM, et al. Cardiac output and cardiac index measured with cardiovascular magnetic resonance in healthy subjects, elite athletes and patients with congestive heart failure[J]. J Cardiovasc Magn Resou, 2012, 14(1): 51.
10Ordovas KG, Carlsson M, Lease KE, et al. Impaired regional left ventricular strain after repair of tetralogy of Fallot [J]. J Magn Reson Imaging, 2012, 35(1): 79-85.
4Cohen JE, Boitsova S, hshayek E. Cerebral venous sinus thrombosis [J]. Isr Med Assoc J, 2009, 11 : 685-688.
5Saadatnia M, Fatehi F, Basiri K, et al. Cerebral venous sinus thrombosis risk factors [J]. Int J Stroke, 2009, 4 : 111- 123.
6Kothur K, Kaul S, Rammurthi S, et al. Use of thrombolytic therapy in cerebral venous sinus thrombosis with ulcerative colitis [J]. Ann Indian Acad Neurol, 2012, 15.. 35-38.
7Park JH, Yoon SH. New concept of cerebrospinal fluid dy namics in cerebral venous sinus thrombosis [J]. Med Hypot heses, 2008, 70: 143-147.
8Ennaifer R, Moussa A, Mouelhi L, et al. Cerebral venous sinus thrombosis as presenting feature of ulcerative colitis [J]. Acta Gastroenterol Belg, 2009, 72 : 350-353.
9Lettau M, Laible M, Barrows RJ, et al. 3-T contrast-enhanced MR angiography with parallel imaging in cerebral venous and sinus thrombosis [J]. J Neuroradiol, 2011, 38: 275-282.
10Wang D, Fang B, Wei S. Analysis of clinical features of ocular presentation in cranial venous sinus thrombosis [J]. Eur J Med Res, 2011, 16.. 324-327.
